World's Best Scientists 2026 revealed!
Ritsuro Suzuki

Ritsuro Suzuki

D-Index & Metrics

Medicine

D-Index
78
Citations
25037
World Ranking
17957
National Ranking
574

Ritsuro Suzuki publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ritsuro Suzuki sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 443 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ritsuro Suzuki D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ritsuro Suzuki sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ritsuro Suzuki is affiliated with Shimane University in Japan and has contributed extensively to the field of medicine, with a focus on pathology, hematology, oncology, genetics, and immunology. Their research spans multiple aspects of hematologic malignancies and related disorders.

The scientist's significant areas of work include lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, central nervous system lymphoma diagnosis and treatment, hematopoietic stem cell transplantation, immune cell function and interaction, viral-associated cancers and disorders, and chronic myeloid leukemia treatments.

Ritsuro Suzuki's frequent co-authors include Yoshiko Atsuta, Noriko Fukuhara, Ayumi Fujimoto, Kana Miyazaki, and Motoko Yamaguchi, reflecting extensive collaboration within their research field.

The research outputs have been published in notable venues, with the most frequent publication platforms being Hematological Oncology, Blood, International Journal of Hematology, Bone Marrow Transplantation, and Annals of Hematology.

Among the recent scholarly articles authored or co-authored by Suzuki are:

  • Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial, 2020, The Lancet Oncology
  • Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients, 2020, Blood Advances
  • Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations, 2021, Leukemia
  • Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia, 2023, Leukemia
  • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes, 2020, Cancers

Best Publications

  • Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

    Yukiya Yamamoto;Hitoshi Kiyoi;Yasuyuki Nakano;Ritsuro Suzuki

  • RET, ROS1 and ALK fusions in lung cancer.

    Kengo Takeuchi;Manabu Soda;Yuki Togashi;Ritsuro Suzuki

  • A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

    Motoko Yamaguchi;Yok Lam Kwong;Won Seog Kim;Yoshinobu Maeda

  • Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

    Takashi Oyama;Kazuhito Yamamoto;Naoko Asano;Aya Oshiro

  • A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.

    Tomoaki Akagi;Mutsuhito Motegi;Akiko Tamura;Ritsuro Suzuki

  • Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.

    Takuhei Murase;Motoko Yamaguchi;Ritsuro Suzuki;Masataka Okamoto

  • Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

    Yoshiko Atsuta;Ritsuro Suzuki;Ayami Yoshimi;Hisashi Gondo

  • De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

    Motoko Yamaguchi;Masao Seto;Masataka Okamoto;Ryo Ichinohasama

  • Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

    Tatsuya Suzuki;Hitoshi Kiyoi;Kazutaka Ozeki;Akihiro Tomita

  • Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

    Hiroyuki Tagawa;Sivasundaram Karnan;Ritsuro Suzuki;Keitaro Matsuo

  • Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

    Takashi Oyama;Koichi Ichimura;Ritsuro Suzuki;Junji Suzumiya

  • A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

    Seok Jin Kim;Dok Hyun Yoon;Arnaud Jaccard;Wee Joo Chng

  • Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

    Masakatsu Hishizawa;Junya Kanda;Atae Utsunomiya;Shuichi Taniguchi

  • Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.

    R Suzuki;J Suzumiya;S Nakamura;S Aoki

  • Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia

    Yoshiko Atsuta;Ritsuro Suzuki;Tokiko Nagamura-Inoue;Shuichi Taniguchi

  • Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

    Yasushi Yatabe;Ritsuro Suzuki;Kensei Tobinai;Yoshihiro Matsuno

  • Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

    R. Suzuki;J. Suzumiya;M. Yamaguchi;S. Nakamura

  • Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.

    Motoko Yamaguchi;Ritsuro Suzuki;Yok-Lam Kwong;Won Seog Kim

  • Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Sonali M. Smith;Linda J. Burns;Koen W. van Besien;Jennifer LeRademacher

Frequent Co-Authors

Yasuo Morishima
Yasuo Morishima Aichi Medical University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Masao Seto
Masao Seto Kurume University
Tomoki Naoe
Tomoki Naoe Nagoya University
Tadashi Yoshino
Tadashi Yoshino Okayama University
Toshihiro Miyamoto
Toshihiro Miyamoto Kyushu University
Ryuzo Ueda
Ryuzo Ueda Nagoya University
Koichi Ohshima
Koichi Ohshima Kurume University
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Nobuyuki Hamajima
Nobuyuki Hamajima Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While a traditional medical degree in the USA is highly competitive, there are several related online degrees and career pathways in healthcare worth exploring. Many students consider alternative routes such as nursing, healthcare administration, or medical billing and coding—all of which offer rewarding opportunities without requiring lengthy or highly selective medical school admissions.

For those interested in nursing, nursing schools with high acceptance rates can help you start a healthcare career sooner, especially if you seek a less competitive entry point. If you already have a nursing background, lpn to rn programs without teas test offer accelerated paths—and you may even bypass challenging entrance exams.

Non-clinical roles are also in demand. If you prefer administrative or support positions, explore medical billing and coding online schools that accept financial aid, which can prepare you for entry-level jobs with flexible study options. Additionally, building leadership skills through an accelerated healthcare administration degree online opens doors to management positions in hospitals, clinics, and beyond.

Best Scientists Citing Ritsuro Suzuki

Trending Scientists

Recently Published Articles